Hammersmith Hospitals NHS Trust
10
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
10.0%
1 terminated/withdrawn out of 10 trials
87.5%
+1.0% vs industry average
20%
2 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Early Administration of Romidepsin and 3BNC117 in Treatment-naïve HIV Patients Starting ART
Role: collaborator
Prevention of Dysrhythmias on the Cardiac Intensive Care Unit - Does Maintenance of High-normal Serum Potassium Levels Matter
Role: collaborator
RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome
Role: collaborator
Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive Infections
Role: collaborator
Investigation of Coagulation Parameters in Hereditary Haemorrhagic Telangiectasia
Role: collaborator
Detecting Markers of Kidney Function With Intravenous Microdialysis
Role: collaborator
Diagnostic Accuracy of MRI, DWI MRI, FDG-PET/CT and FEC PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical Carcinoma
Role: collaborator
The Influence of Psychological Interventions Upon Disease Progression in HIV-infected Patients Receiving no Medication
Role: collaborator
Comparison of Imatinib Versus Dasatinib in Patients With Newly-diagnosed Chronic Phase Chronic Myeloid Leukaemia
Role: collaborator
Erythropoietin in Acute Myocardial Infarction
Role: lead
All 10 trials loaded